These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2477896)

  • 1. [A gene probe test for serum RNA proteolipid in neoplasia].
    Wieczorek AJ; Rhyner K
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1342-3. PubMed ID: 2477896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic value of RNA-proteolipid in sera of patients with malignant disorders following therapy: first clinical evaluation of a novel tumor marker.
    Wieczorek AJ; Sitaramam V; Machleidt W; Rhyner K; Perruchoud AP; Block LH
    Cancer Res; 1987 Dec; 47(23):6407-12. PubMed ID: 2445471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?
    Schmidt B; Engel E; Carstensen T; Weickmann S; John M; Witt C; Fleischhacker M
    Lung Cancer; 2005 Apr; 48(1):145-7. PubMed ID: 15777983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum.
    Kopreski MS; Benko FA; Gocke CD
    Ann N Y Acad Sci; 2001 Sep; 945():172-8. PubMed ID: 11708475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
    Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
    Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC; Cheng W; Lai PL
    Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma.
    Last KW; Cornelius V; Delves T; Sieniawska C; Fitzgibbon J; Norton A; Amess J; Wilson A; Rohatiner AZ; Lister TA
    J Clin Oncol; 2003 Jun; 21(12):2335-41. PubMed ID: 12805335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
    Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
    Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods.
    Rykova EY; Wunsche W; Brizgunova OE; Skvortsova TE; Tamkovich SN; Senin IS; Laktionov PP; Sczakiel G; Vlassov VV
    Ann N Y Acad Sci; 2006 Sep; 1075():328-33. PubMed ID: 17108228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
    Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
    Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEACAM1, a novel serum biomarker for pancreatic cancer.
    Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
    Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
    Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
    Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sialic acid--an important cancer marker.
    Tewarson SL; Mittal VP; Singh M; Gupta GP
    Indian J Cancer; 1993 Sep; 30(3):125-31. PubMed ID: 8300142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.